Description
Stelfonta is a ground-breaking new treatment for canine mast cell tumours (MCTs). In this webinar Dr Pam Jones will introduce delegates to the unique mode of action of Tigilanol tiglate, review the efficacy data behind this new product and demonstrate how this highly innovative yet simple treatment can be used to provide a high tumour elimination rate, wound healing and a speedy return to a good quality of life for the pet.
NB: This webinar is intended for a UK audience.
Find out more information via the website
And the database here.
